BMJ Open,
Journal Year:
2025,
Volume and Issue:
15(3), P. e089355 - e089355
Published: March 1, 2025
Introduction
Gestational
diabetes
mellitus
(GDM)
is
increasingly
becoming
a
serious
public
health
challenge.
Innovative,
effective
and
scalable
lifestyle
interventions
to
support
women
with
GDM
manage
their
condition
prevent
adverse
obstetric
neonatal
outcomes
as
well
later
morbidity
are
required.
This
study
aims
evaluate
whether
novel,
multilingual
mobile
(mHealth)
intervention
(SPARK;
SmartPhone
App
for
gestational
patients
suppoRting
Key
behaviours
glucose
control)
can
improve
self-management
treatment
of
maternal
offspring
outcomes.
Methods/analyses
SPARK
multicentre
two-arm
randomised
controlled
trial
recruiting
diagnosed
in
south-eastern
Sweden.
A
total
412
will
be
either
standard
care
(control)
or
the
intervention.
The
online
platform
(accessed
through
app)
provides
behaviour
change
programme
healthy
eating,
physical
activity
glycaemic
control.
To
increase
reach,
available
Swedish,
English,
Arabic
Somali.
also
comes
clinician
portal
where
healthcare
professionals
monitor
intervene
when
control
unsatisfactory
(above
certain
cut-offs).
Primary
that
is,
time
range
HbA1c,
while
diet,
(ActiGraph),
weight
gain,
metabolic
inflammatory
biomarkers
weeks
37–38,
adherence
protocol
daily
sampling,
secondary
Secondary
include
cardiometabolic
risk
evaluation,
eating
1
year
postpartum.
economic
evaluation
vs
conducted.
Ethics
dissemination
has
been
approved
by
Swedish
Ethical
Review
Authority
(2021-06627-01;
2022-03842-02;
2023-05911-02).
Results
disseminated
scientific
papers
peer-reviewed
journals,
posts
traditional
social
media,
presentations
at
professionals’
conferences.
Trial
registration
number
was
registered
ClinicalTrials.gov
register
(ID
NCT05348863
)
27
April
2022.
Diabetes Obesity and Metabolism,
Journal Year:
2024,
Volume and Issue:
26(S1), P. 46 - 56
Published: March 1, 2024
Abstract
Diabetes
is
a
complex
metabolic
condition
that
demands
tailored,
individualized
approaches
for
effective
management.
Real‐time
continuous
glucose
monitoring
(rtCGM)
systems
have
improved
in
terms
of
design,
usability
and
accuracy
over
the
years
play
pivotal
role
delivery
integrated
personalized
diabetes
management
(iPDM).
iPDM
comprehensive
multidisciplinary
approach
combines
care
strategies
utilizing
technologies
interventions
encourages
active
involvement
person
with
provided.
The
use
stand‐alone
rtCGM
its
integration
other
technologies,
such
as
hybrid
automated
insulin
delivery,
enabled
glycaemic
quality
life
outcomes
people
diabetes.
As
uptake
associated
increasing
becoming
standard
diabetes,
it
important
efforts
are
focused
on
goals
reducing
health
inequalities
access,
aligning
structured
education
usage,
choosing
right
technology
based
needs
preferences,
minimizing
burden
while
aiming
optimal
outcomes.
Utilizing
settings
than
outpatients
cohorts
beyond
type
1
2
further
exploration.
This
review
aims
to
provide
an
overview
how
best
link
iPDM,
highlighting
enhancing
treatment
strategies.
Cureus,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Oct. 13, 2024
Magnesium
(Mg),
an
essential
mineral
abundantly
present
within
the
human
body,
is
intricately
involved
in
a
multitude
of
biochemical
processes
vital
for
maintaining
health
and
overall
well-being.
This
review
aims
to
delve
into
multifaceted
impact
Mg
on
health,
exploring
its
physiological
functions,
dietary
sources,
potential
implications
deficiency
or
insufficiency.
plays
pivotal
role
various
processes,
including
energy
metabolism,
muscle
contraction,
protein
synthesis,
DNA
synthesis.
It
acts
as
cofactor
more
than
300
enzymatic
reactions,
facilitating
conversion
adenosine
triphosphate
(ATP)
diphosphate
(ADP)
production.
Moreover,
proper
functioning
ion
channels,
particularly
calcium
influencing
nerve
transmission
relaxation.
naturally
found
wide
array
foods,
with
green
leafy
vegetables,
whole
grains,
nuts,
seeds,
legumes
being
rich
sources.
Additionally,
certain
fortified
foods
supplements
provide
supplemental
intake.
Deficiency
insufficiency
mg
can
have
profound
health.
Inadequate
levels
been
associated
increased
risks
chronic
diseases,
hypertension,
type
2
diabetes,
osteoporosis,
cardiovascular
diseases.
Furthermore,
may
manifest
symptoms
such
weakness,
fatigue,
tremors,
irregular
heartbeat.
Numerous
studies
elucidated
relationship
between
intake
risk
developing
For
instance,
epidemiological
evidence
suggests
that
higher
reduced
possibly
due
vasodilatory
effects
influence
blood
pressure
regulation
mechanisms.
Similarly,
has
implicated
pathophysiology
contributing
insulin
resistance
impaired
glucose
metabolism.
adequate
crucial
bone
density
reducing
mineralization
Understanding
importance
physiology
underscores
significance
ensuring
through
diet
supplementation.
Healthcare
professionals
play
critical
educating
individuals
about
incorporating
mg-rich
their
diets
considering
supplementation
when
necessary,
at
those
indispensable
far-reaching
Its
involvement
Ensuring
preventing
deficiency-related
complications
Further
research
warranted
elucidate
optimal
strategies
therapeutic
applications
disease
prevention
management.
Diabetes Obesity and Metabolism,
Journal Year:
2024,
Volume and Issue:
26(S3), P. 31 - 41
Published: July 4, 2024
Abstract
Metformin
is
best
known
as
a
foundational
therapy
for
type
2
diabetes
but
also
used
in
other
contexts
clinical
medicine
with
number
of
emerging
and
potential
indications.
Many
its
beneficial
effects
may
be
mediated
by
modest
on
weight
loss
insulin
sensitivity,
it
has
multiple
mechanisms
action.
Current
uses
beyond
include:
polycystic
ovarian
syndrome;
pregnancy/gestational
diabetes;
prevention
prediabetes;
adjunct
1
diabetes.
As
metformin
been
use
almost
70
years,
much
the
underpinning
evidence
these
conditions
is,
definition,
based
trials
conducted
before
advent
contemporary
evidence‐based
medicine.
result,
some
above‐established
are
‘off‐label’
many
regulatory
territories
their
varies
accordingly
different
countries.
Going
forward,
several
current
‘repurposing’
investigational
being
investigated:
cancer
(including
Li
Fraumeni
syndrome),
renal
protection,
Alzheimer's
disease,
metabolic
dysfunction‐associated
steatotic
liver
disease
promotion
healthy
ageing.
Despite
longevity
important
roles
medicine,
further
research
ongoing.
Diabetes Care,
Journal Year:
2024,
Volume and Issue:
47(4), P. 544 - 555
Published: March 25, 2024
This
statement
provides
guidance
for
diabetes
care
in
detention
facilities.
It
focuses
on
areas
where
the
processes
delivery
of
to
people
with
facilities
may
differ
from
those
community,
and
key
points
are
made
at
end
each
section.
Areas
emphasis,
which
inform
multiple
aspects
discussed
this
statement,
include
1)
timely
identification
or
diagnosis
treatment
needs
continuity
(at
reception/intake,
during
transfers,
upon
discharge),
2)
nutrition
physical
activity,
3)
access
management
tools
(insulin,
blood
glucose
monitoring,
tracking
data,
current
technologies,
etc.),
4)
whole
person
(self-management
education,
mental
health
support,
monitoring
addressing
long-term
complications,
specialty
care,
etc.).
Contraception,
Journal Year:
2025,
Volume and Issue:
unknown, P. 110860 - 110860
Published: Feb. 1, 2025
Nonalcoholic
fatty
liver
disease
(NAFLD)
is
an
increasing
concern
among
women
with
a
history
of
gestational
diabetes
mellitus
(GDM).
Hormonal
contraceptives
may
affect
metabolism,
potentially
NAFLD
risk.
This
study
examined
the
association
between
different
contraceptive
methods
and
risk
approximately
one
year
postpartum
in
prior
GDM.
We
conducted
prospective
cohort
involving
130
categorized
these
into
three
groups
based
on
their
use:
no
contraception
or
non-hormonal
(n
=
86);
progestin-only
(POCs),
including
pills
(POPs),
depot
medroxyprogesterone
acetate
(DMPA),
implants
29);
combined
oral
(COCs)
15).
At
postpartum,
we
measured
controlled
attenuation
parameter
to
assess
hepatic
steatosis
diagnose
NAFLD.
used
multivariable
logistic
regression
analyses
evaluate
The
POC
group
had
highest
median
(307
dB/m)
prevalence
(55.2%),
followed
by
(237
dB/m;
30.2%),
lowest
values
COC
(213
13.3%).
POCs,
particularly
POPs
DMPA,
significantly
increased
compared
(adjusted
odds
ratio
4.28,
95%
confidence
interval
1.55-11.85).
In
contrast,
COCs
did
not
show
significant
risk,
whereas
showed
such
association.
These
findings
have
important
implications
for
counseling
Echocardiography,
Journal Year:
2025,
Volume and Issue:
42(4)
Published: April 1, 2025
ABSTRACT
Objective
Gestational
diabetes
mellitus
(GDM)
is
a
transient
metabolic
disorder
associated
with
hyperglycemia,
insulin
resistance,
and
endothelial
dysfunction.
Although
GDM
typically
resolves
after
delivery,
it
can
have
long‐term
effects
on
both
maternal
fetal
health,
including
potential
cardiovascular
complications
for
the
offspring.
This
study
aims
to
evaluate
impact
of
hyperglycemia
cardiac
function
using
advanced
HQ
(fetal
heart
quantification)
imaging
technology.
Methods
A
prospective
was
conducted
from
July
2019
November
2024,
involving
303
pregnant
women
in
their
second
third
trimesters,
105
(well‐controlled)
198
healthy
controls.
Fetal
assessed
imaging,
two‐dimensional
speckle‐tracking
echocardiography
technique.
Measurements
global
longitudinal
strain
(GLS),
fractional
area
change
(FAC),
shortening
(FS)
were
obtained
left
(LV)
right
(RV)
ventricles.
Correlations
between
factors
(BMI,
HbA1c,
triglycerides)
parameters
also
evaluated.
Intra‐
inter‐rater
reliability
all
measurements.
Results
The
group
exhibited
significantly
lower
LV
GLS
compared
control
(−21.5
±
5.5%
vs.
−24.5
4.9%,
p
=
0.000),
indicating
impaired
myocardial
deformation.
No
significant
differences
found
RV
GLS,
FAC,
or
ejection
fraction
(EF).
Significant
24‐segment
FS
values
observed
RV,
showing
across
most
segments,
suggesting
subclinical
Reliability
analysis
demonstrated
high
intra‐
consistency
measurements,
excellent
intra‐rater
(ICC
0.912)
strong
0.725).
HbA1c
triglycerides
negatively
correlated
that
may
affect
ventricular
function.
Conclusion
demonstrates
function,
particularly
deformation,
as
measured
by
FS.
Maternal
factors,
triglycerides,
are
linked
these
alterations.
reliable
method
assessing
provides
valuable
insights
into
fetus.
Annals of Internal Medicine,
Journal Year:
2024,
Volume and Issue:
177(6), P. ITC81 - ITC96
Published: June 1, 2024
Type
2
diabetes
(T2D)
is
a
prevalent
disease
that
increases
risk
for
vascular,
renal,
and
neurologic
complications.
Prevention
treatment
of
T2D
its
complications
are
paramount.
Many
advancements
in
care
have
emerged
over
the
past
5
years,
including
increased
understanding
importance
early
intensive
glycemic
control,
mental
health,
social
determinants
healthy
eating
patterns,
continuous
glucose
monitoring,
benefits
some
drugs
preventing
cardiorenal
disease.
This
review
summarizes
evidence
supporting
prevention
treatment,
focusing
on
aspects
commonly
purview
primary
physicians.
Diabetes Care,
Journal Year:
2024,
Volume and Issue:
47(7), P. 1104 - 1110
Published: March 29, 2024
Hemoglobin
A1c
(A1C)
is
widely
used
for
the
diagnosis
and
management
of
diabetes.
Accurate
measurement
A1C
necessary
optimal
clinical
value.
Assay
standardization
has
markedly
improved
accuracy
consistency
testing.
Devices
to
measure
at
point
care
(POC)
are
commercially
available,
allowing
rapid
results
when
patient
seen.
In
this
review,
we
describe
how
testing
was
achieved,
leading
high-quality
in
laboratories.
We
address
use
POC
situations
summarize
advantages
disadvantages
emphasize
importance
considering
limitations
these
devices
following
correct
procedures
ensure
that
accurate
obtained
patients.
Diabetes Obesity and Metabolism,
Journal Year:
2024,
Volume and Issue:
26(S3), P. 42 - 54
Published: July 10, 2024
Metformin
is
the
first-line
medication
for
type
2
diabetes.
It
effective
and
safe,
provided
some
caution
taken
in
specific
populations.
In
patients
with
chronic
kidney
disease,
metformin
may
provide
long-term
benefits,
it
a
therapy
diabetes,
but
estimated
glomerular
filtration
rate
(eGFR)
must
be
assessed
regularly,
to
minimize
risk
accumulation.
When
eGFR
30-60
mL/min/1.73m